SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-21-054252
Filing Date
2021-11-04
Accepted
2021-11-04 07:55:56
Documents
90
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q ortx-10q_20210930.htm   iXBRL 10-Q 3928809
2 EX-10.1 ortx-ex101_194.htm EX-10.1 104136
3 EX-31.1 ortx-ex311_7.htm EX-31.1 19290
4 EX-31.2 ortx-ex312_8.htm EX-31.2 19263
5 EX-32.1 ortx-ex321_6.htm EX-32.1 12423
  Complete submission text file 0001564590-21-054252.txt   12512893

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA ortx-20210930.xsd EX-101.SCH 75159
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ortx-20210930_cal.xml EX-101.CAL 81517
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ortx-20210930_def.xml EX-101.DEF 207777
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE ortx-20210930_lab.xml EX-101.LAB 531706
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ortx-20210930_pre.xml EX-101.PRE 406713
11 EXTRACTED XBRL INSTANCE DOCUMENT ortx-10q_20210930_htm.xml XML 2332473
Mailing Address 108 CANNON STREET LONDON X0 EC4N 6EU
Business Address 108 CANNON STREET LONDON X0 EC4N 6EU 011-44-0-203-3846700
Orchard Therapeutics plc (Filer) CIK: 0001748907 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38722 | Film No.: 211378067
SIC: 2836 Biological Products, (No Diagnostic Substances)